By using cell cultures and xenograft mouse models, recent studies found that inhibition of HTR2B-mediated serotonin signaling suppressed tumor growth in CRC [13], and that HTR2B facilitated metastasis [14]. The gene discussed is HTR2B; the disease is neoplasm.